Dycom Industries Inc
Construction
Dycom Industries Inc (DY) Stock News
The latest DY headlines and market coverage — 5 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
GDDY Investor News: If You Have Suffered Losses in GoDaddy Inc. (NYSE: GDDY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm has announced an investigation into potential securities claims against GoDaddy Inc. (NYSE: GDDY) for allegedly issuing materially misleading business information to investors. The firm is preparing a class action lawsuit to recover investor losses and encourages affected shareholders to join the prospective class action.
- Benzinga·
GROUPE DYNAMITE POSTS 37% REVENUE GROWTH AND 4-YEAR HIGH GROSS MARGIN IN Q1 2026
Delivered strong Q1 2026 comparable store sales growth 1 of 22.6% and total revenue growth of 37.0% Achieved a four-year high gross margin 1 of 67.4 %, an increase of 530 bps Expanded adjusted EBITDA margin 1 to 36.8 %, underscoring our luxury-inspired business model Continued successful expansion with new stores outperforming expectations Raised adjusted EBITDA margin guidance for Fiscal 2026 to 38.25%–39.50 % MONTRÉAL , June 16, 2026 /CNW/ - Groupe Dynamite Inc. ("Groupe Dynamite" or the "Company") (TSX: GRGD ) today reported its financial results for the fiscal year 2026's first quarter ended May 2, 2026. "Our first quarter results demonstrate the strength of our operating model and our ability to deliver profitable growth. Comparable store sales increased 22.6%, gross margin reached a four-year high, and adjusted EBITDA margin expanded to 36.8% of revenue, positioning ourselves alongside the world's most profitable fashion houses. We continue to strive to remain a highly productive specialty retailer with strong brands, exceptional unit economics, disciplined inventory management, attractive returns on capital, and a growth engine we have built over decades that continues to scale profitably," said Andrew Lutfy, Chief Executive Officer and Chair of the Board. "Q1 was a strong start to fiscal 2026. Across both GARAGE and DYNAMITE, customers responded positively to our assortments, marketing campaigns and the consistency of the experience we deliver across channels. Our real estate strategy continues to be a significant driver of growth, customer acquisition and profitability. By opening new locations in premium centers, optimizing our fleet and delivering a compelling in-store experience, we continue to drive significant productivity improvements across our store network. Most importantly, we continue to see strong customer engagement across both brands, reflected
- GlobeNewswire Inc.·
GDDY Investor News: If You Have Suffered Losses in GoDaddy Inc. (NYSE: GDDY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm has announced an investigation into potential securities claims against GoDaddy Inc. (NYSE: GDDY) for allegedly issuing materially misleading business information to investors. The firm is preparing a class action lawsuit to recover investor losses and encourages affected shareholders to join the prospective class action.
- Benzinga·
Streamex Corp. Announces April 2026 Yield Dividend Distribution for GLDY
Streamex Corp. (NASDAQ:STEX) announced its second monthly yield distribution for GLDY, a gold-backed tokenized security. GLDY holders received 0.002677 GLDY per token for April 2026, generated through an institutional gold leasing program earning 3.5% annualized yield. The company plans to scale the program and expand secondary trading venues.
- GlobeNewswire Inc.·
DYSPORT Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
A comprehensive market analysis report on Dysport (Ipsen's botulinum toxin type A) projects strong growth through 2034, driven by expanding neuromodulator and aesthetic injectable markets expected to reach $11.3B by 2028. Dysport holds 12% market share against Botox's 72%, leveraging competitive pricing and expanding therapeutic applications in neurological conditions. The report covers seven major markets including the US, EU4, UK, and Japan.